Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer

Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer

Background: Real-world data on palliative systemic therapies (PST) in treating metastatic bladder cancer (mBC) is limited. This study investigates current trends in treating mBC with first- (1L) and second-line (2L) chemotherapy (CT) and immunotherapy (IT). Methods: A chart review was conducted on p...

Full description

Bibliographic Details
Main Authors: Arshia Beigi, Saba Vafaei-Nodeh, Longlong Huang, Shaun Z. Sun, Jenny J. Ko
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Current Oncology
Subjects:
metastatic bladder cancer
chemotherapy
immunotherapy
survival
real-world data
Online Access:https://www.mdpi.com/1718-7729/28/5/325

Similar Items

Similar Items